{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-001212","form_type":"8-K","ticker":"PTN","cik":"0000911216","company_name":"PALATIN TECHNOLOGIES INC","filed_at":"2024-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.254903+00:00","generated_at":"2026-06-06T12:31:52.438416+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Palatin closes $10M registered direct offering; details Vyleesi sale to Cosette with $12M upfront","bullets":["Registered direct offering closed Feb 1: 1,831,503 shares at $5.46, gross $10M, net proceeds ~$9.2M.","Warrants for 1,831,503 shares at $5.46, exercisable after 6 months for 4 years; placement agent warrants 91,575 at $6.825.","Vyleesi sale to Cosette closed Dec 20: $12M upfront ($9.5M at close, $2.5M in 12 months), up to $159M sales milestones.","Regulatory milestones up to $10.5M from Fosun (China) and Kwangdong (S. Korea) associated with Vyleesi licensing.","Net proceeds for working capital; Vyleesi divestiture refocuses pipeline on melanocortin receptor modulators."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-001212","json":"https://secwatch.observer/filing/0001654954-24-001212.json","markdown":"https://secwatch.observer/filing/0001654954-24-001212.md","text":"https://secwatch.observer/filing/0001654954-24-001212.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/911216/000165495424001212/0001654954-24-001212-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/911216/000165495424001212/ptn_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T12:31:52.438416+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e8a8b8b1f71d623bb462d50b587b65beec8efd0e","claim":"PALATIN TECHNOLOGIES INC entered into Purchase Agreement with investors named on the signature page thereto (effective 2024-01-29).","evidence_excerpt":"On January 29, 2024, Palatin Technologies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the investors named on the signature page thereto, to sell in a registered direct offering (the “RD Offering”), an aggregate of 1,831,503 shares of common stock, $0.01 par value per share (the “Shares”), of the Company.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/911216/000165495424001212/0001654954-24-001212-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"investors named on the signature page thereto"},{"label":"Effective","value":"2024-01-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}